CliffBio

Blueprint Medicines

Patent cliffs & loss of exclusivity

Blueprint Medicines is a biotechnology company that is working to improve human health.

Company

AngelList URLhttps://angel.co/blueprint-medicines
CAGE Code6NX60
Legal NameBlueprint Medicines Corporation
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/blueprint-medicines
Facebook URLhttps://www.facebook.com/pages/Blueprint-Medicines/1379814272250150
Full AddressBaarerstrasse 8 6300 Zug Switzerland
LinkedIn URLhttp://www.linkedin.com/company/blueprint-medicines

5 upcoming patent cliffs

DrugIngredientTypeCliff
  1. AYVAKITAVAPRITINIBSmall mol.Apr 2040
  2. AYVAKITAVAPRITINIBSmall mol.Apr 2040
  3. AYVAKITAVAPRITINIBSmall mol.Mar 2042
  4. AYVAKITAVAPRITINIBSmall mol.Mar 2042
  5. AYVAKITAVAPRITINIBSmall mol.Mar 2042

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Blueprint Medicines — patent cliffs & loss of exclusivity | CliffBio